Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna J Harrison

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Annals of Pharmacotherapy|December 24, 2010
Defining reality: the potential role of pharmacists in assessing the impact of progesterone receptor modulators and misoprostol in reproductive healthDonna J Harrison, James G Mitroka
The Annals of Pharmacotherapy|December 29, 2005
Analysis of severe adverse events related to the use of mifepristone as an abortifacientMargaret M Gary, Donna J Harrison
Health Services Research and Managerial Epidemiology|January 7, 2022
Mifepristone Adverse Events Identified by Planned Parenthood in 2009 and 2010 Compared to Those in the FDA Adverse Event Reporting System and Those Obtained Through the Freedom of Information ActChristina A Cirucci, Kathi A Aultman, Donna J Harrison
Online Journal of Public Health Informatics|October 22, 2019
Improving the Metrics and Data Reporting for Maternal Mortality: A Challenge to Public Health Surveillance and Effective PreventionJames Studnicki, David C Reardon, Donna J Harrison, et al.
Health Services Research and Managerial Epidemiology|August 27, 2020
Pregnancy Outcome Patterns of Medicaid-Eligible Women, 1999-2014: A National Prospective Longitudinal StudyJames Studnicki, John W Fisher, David C Reardon, et al.
Journal of Primary Care & Community Health|May 7, 2021
Estimating the Period Prevalence of Publicly Funded Abortion to Space Live Births, 1999 to 2014James Studnicki, John W Fisher, Tessa Longbons, et al.
Health Services Research and Managerial Epidemiology|April 26, 2019
Doctors Who Perform Abortions: Their Characteristics and Patterns of Holding and Using Hospital PrivilegesJames Studnicki, Tessa Longbons, John W Fisher, et al.
Issues in Law & Medicine|May 3, 2021
Deaths and Severe Adverse Events after the use of Mifepristone as an Abortifacient from September 2000 to February 2019Kathi Aultman, Christina A Cirucci, Donna J Harrison, et al.
Health Services Research and Managerial Epidemiology|November 15, 2021
A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999-2015James Studnicki, Donna J Harrison, Tessa Longbons, et al.
Health Services Research and Managerial Epidemiology|August 9, 2021
Estimating the Period Prevalence of Mothers Who Have Abortions: A Population Based Study of Inclusive Pregnancy OutcomesJames Studnicki, John W Fisher, Tessa Longbons, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Annals of Pharmacotherapy|December 24, 2010
Defining reality: the potential role of pharmacists in assessing the impact of progesterone receptor modulators and misoprostol in reproductive healthDonna J Harrison, James G Mitroka
The Annals of Pharmacotherapy|December 29, 2005
Analysis of severe adverse events related to the use of mifepristone as an abortifacientMargaret M Gary, Donna J Harrison
Health Services Research and Managerial Epidemiology|January 7, 2022
Mifepristone Adverse Events Identified by Planned Parenthood in 2009 and 2010 Compared to Those in the FDA Adverse Event Reporting System and Those Obtained Through the Freedom of Information ActChristina A Cirucci, Kathi A Aultman, Donna J Harrison
Online Journal of Public Health Informatics|October 22, 2019
Improving the Metrics and Data Reporting for Maternal Mortality: A Challenge to Public Health Surveillance and Effective PreventionJames Studnicki, David C Reardon, Donna J Harrison, et al.
Health Services Research and Managerial Epidemiology|August 27, 2020
Pregnancy Outcome Patterns of Medicaid-Eligible Women, 1999-2014: A National Prospective Longitudinal StudyJames Studnicki, John W Fisher, David C Reardon, et al.
Journal of Primary Care & Community Health|May 7, 2021
Estimating the Period Prevalence of Publicly Funded Abortion to Space Live Births, 1999 to 2014James Studnicki, John W Fisher, Tessa Longbons, et al.
Health Services Research and Managerial Epidemiology|April 26, 2019
Doctors Who Perform Abortions: Their Characteristics and Patterns of Holding and Using Hospital PrivilegesJames Studnicki, Tessa Longbons, John W Fisher, et al.
Issues in Law & Medicine|May 3, 2021
Deaths and Severe Adverse Events after the use of Mifepristone as an Abortifacient from September 2000 to February 2019Kathi Aultman, Christina A Cirucci, Donna J Harrison, et al.
Health Services Research and Managerial Epidemiology|November 15, 2021
A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999-2015James Studnicki, Donna J Harrison, Tessa Longbons, et al.
Health Services Research and Managerial Epidemiology|August 9, 2021
Estimating the Period Prevalence of Mothers Who Have Abortions: A Population Based Study of Inclusive Pregnancy OutcomesJames Studnicki, John W Fisher, Tessa Longbons, et al.
Pageof 2